Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Pohl.....

What I love about this board is the sheer intellectual power that is available to debate, discuss, persuade, and ponder.  Point – counterpoints.  Interesting thought but here is why I think you are wrong.  Outstanding.

And with that said, how about the fact that we served notice to 150 companies with a flurry of signings, then we announced the notices had been served to 300 companies, and now it is 400 companies.  More and more companies being served.  All on hold pending trial?  Strategy to almost finalize negotiations awaiting the right time to finalize?  Or are the newly served companies yawning and ignoring us?  If they were impressed, wouldn’t they be scrambling to buy some of this undervalued stock? 

Did Fish sign and complete the deal?  Don’t need complications.

How come only a few out there think the BOD should purchase shares on their own dime?

Our CEO insists his people below him show support by purchasing shares (in addition to the options granted).  Implied pressure to keep one’s position.  Not such a bad thing.  Having some skin in the game.  Some are saying there is accumulation and are speculating it is TPL.  I think that would be GREAT news for longs.  Not sure why they think TPL would want to though.  They already will be rewarded if successful without much risk.  Why add risk.  Every day increased volume, lower share price.  Harder and harder to climb back when and if we ever get good news.  Digging too much of a hole.

Share
New Message
Please login to post a reply